International Scientific Conference on Probiotics and Prebiotics (IPC) 2016
ILSI Europe’s session on ‘Gut Barrier Function and Microbial Metabolism’ was part of the International Scientific Conference on Probiotics and Prebiotics – IPC2016, that took place from the 21-23 June 2016 in the Mariott Hotel in Budapest, Hungary. For more information about IPC2016, please visit the official conference website: www.probiotic-conference.net
SCIENTIFIC BACKGROUND AND PURPOSE OF THE SESSION
An unhealthy gut contributes to a wide range of diseases including diabetes, obesity or inflammatory diseases. Since it is increasingly acknowledged that the gastrointestinal microbiota plays a major role in the improvement of host health, scientists have a strong interest in the effects of diet on human gastrointestinal microbiota composition. ILSI Europe’s Functional Foods and Prebiotics Task Forces are currently reviewing the available data on different gut microbiota clusters, microbial metabolism and its impact on the bio-availability of a large number of nutrients and non-nutrients.
Furthermore, the intestinal barrier function, microbiota composition and activity can be affected by dietary factors. Thus, functional foods are directed towards digestive health, with prebiotics and probiotics probably being the most common, worldwide. ILSI Europe’s Probiotics Task Force recently assessed the potential impact of probiotics on intestinal barrier function. ILSI Europe’s Prebiotics Task Force also re-evaluated the role of bacterial metabolites, and concluded that changes in bacterial fermentation metabolites could be valuable markers of (prebiotics) health benefits.
The recent conclusions of ILSI Europe’s scientific achievements in prebiotics and probiotics research were presented in this session on 21 June 2016.
Human intestinal barrier function in health & disease
Prof. Jerry Wells (University of Wageningen, NL)
Health benefits of probiotics by impacting intestinal barrier function
Dr Clara Garcia Rodenas (Nestlé, CH)
Influence of gut microbial metabolism on the biochemical profile of dietary compounds
Dr Jonathan Swann (Imperial College London, UK)
Toward microbial fermentation metabolites as markers for health benefits of prebiotics (and probiotics)
Prof. Kieran Tuohy (Fondazione Edmund Mach, IT)
For more information about the session programme, please contact our Scientific Project Manager Dr Tobias Recker at email@example.com.